# Ischemia In Hemodialysed Patients: Ivabradine Versus Carvedilol

Study · id `cardio:ct-nct01425164` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01425164](<https://clinicaltrials.gov/study/NCT01425164>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT01425164

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 220 participants.

## Technical summary

Registry record NCT01425164. Randomized; triple masking; primary purpose treatment. Start 2011-01 (registry gives no type); primary completion 2012-06 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 220 participants (planned count; ClinicalTrials.gov record NCT01425164, source copy `cardio:ctgov-nct01425164-2012-06-28`, retrieved 2026-11-18)
- Start date: 2011-01 (registry gives no type) (ClinicalTrials.gov record NCT01425164, source copy `cardio:ctgov-nct01425164-2012-06-28`, retrieved 2026-11-18)
- Primary completion: 2012-06 (anticipated) (ClinicalTrials.gov record NCT01425164, source copy `cardio:ctgov-nct01425164-2012-06-28`, retrieved 2026-11-18)
- Completion: 2012-06 (anticipated) (ClinicalTrials.gov record NCT01425164, source copy `cardio:ctgov-nct01425164-2012-06-28`, retrieved 2026-11-18)
- Countries: Italy (ClinicalTrials.gov record NCT01425164, source copy `cardio:ctgov-nct01425164-2012-06-28`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01425164-2012-06-28`, retrieved 2026-11-18)

## The registry's words

- Brief title: Ischemia In Hemodialysed Patients: Ivabradine Versus Carvedilol
- Condition: Coronary Heart Disease
- Condition: Angina
- Condition: Hemodialysis
- Intervention (Drug): Ivabradine
- Intervention (Drug): Carvedilol
- Lead sponsor: University of Campania Luigi Vanvitelli
- Lead sponsor class: OTHER
- Collaborator: IRCCS San Raffaele
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Angina pectoris (`cardio:angina-pectoris`)
- Registry intervention name matches this record: Carvedilol (`cardio:carvedilol`)
- Registry lists this organization as the lead sponsor: University of Campania Luigi Vanvitelli (`cardio:org-university-of-campania-luigi-vanvitelli`)
- Registry lists this organization as a collaborator: IRCCS San Raffaele (`cardio:org-irccs-san-raffaele`)

## Provenance

Content hash: fb7c070a2e1356e8b2a4cefdd36a14723a7e231f459ee1de56b89da2749a7528
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
